Dexmedetomidine administration in a patient with status epilepticus under color density spectral array monitoring

Trinka E, Cock H, Hesdorffer D, Rossetti AO, Scheffer IE, Shinnar S, Shorvon S, Lowenstein DH. A definition and classification of status epilepticus--report of the ILAE Task Force on Classification of Status Epilepticus. Epilepsia. 2015;56:1515–23.

Niesen AD, Jacob AK, Aho LE, Botten EJ, Nase KE, Nelson JM, Kopp SL. Perioperative seizures in patients with a history of a seizure disorder. Anesth Analg. 2010;111:729–35.

Kim MJ, Lim DG, Yeo JS. Refractory status epilepticus occurred at the end of sevoflurane anesthesia in patient with epilepsy. Korean J Anesthesiol. 2013;65:93–4.

Neurology TJSo. 2018 Guidelines for the treatment of epilepsy. 2018 [updated 2018; cited 2018 November 26]; Available from: https://www.neurology-jp.org/guidelinem/tenkan_2018.html .

Tanaka K, Oda Y, Funao T, Takahashi R, Hamaoka N, Asada A. Dexmedetomidine decreases the convulsive potency of bupivacaine and levobupivacaine in rats: involvement of alpha2-adrenoceptor for controlling convulsions. Anesth Analg. 2005;100:687–96.

Whittington RA, Virag L, Vulliemoz Y, Cooper TB, Morishima HO. Dexmedetomidine increases the cocaine seizure threshold in rats. Anesthesiology. 2002;97:693–700.

Kurosawa A, Sato Y, Sasakawa T, Kunisawa T, Iwasaki H. Dexmedetomidine inhibits epileptiform activity in rat hippocampal slices. Int J Clin Exp Med. 2017;10:6704–11.

Talke P, Stapelfeldt C, Garcia P. Dexmedetomidine does not reduce epileptiform discharges in adults with epilepsy. J Neurosurg Anesthesiol. 2007;19:195–9.

Oda Y, Toriyama S, Tanaka K, Matsuura T, Hamaoka N, Morino M, Asada A. The effect of dexmedetomidine on electrocorticography in patients with temporal lobe epilepsy under sevoflurane anesthesia. Anesth Analg. 2007;105:1272–7.

Mirski MA, Rossell LA, McPherson RW, Traystman RJ. Dexmedetomidine decreases seizure threshold in a rat model of experimental generalized epilepsy. Anesthesiology. 1994;81:1422–8.

Miyazaki Y, Adachi T, Kurata J, Utsumi J, Shichino T, Segawa H. Dexmedetomidine reduces seizure threshold during enflurane anaesthesia in cats. Br J Anaesth. 1999;82:935–7.

Kubota T, Fukasawa T, Kitamura E, Magota M, Kato Y, Natsume J, Okumura A. Epileptic seizures induced by dexmedetomidine in a neonate. Brain and Development. 2013;35:360–2.

Colin PJ, Hannivoort LN, Eleveld DJ, Reyntjens K, Absalom AR, Vereecke HEM, Struys M. Dexmedetomidine pharmacokinetic-pharmacodynamic modelling in healthy volunteers: 1. Influence of arousal on bispectral index and sedation. Br J Anaesth. 2017;119:200–10.

Pensirikul AD, Beslow LA, Kessler SK, Sanchez SM, Topjian AA, Dlugos DJ, Abend NS. Density spectral array for seizure identification in critically ill children. J Clin Neurophysiol. 2013;30:371–5.

Krishnamurthy KB, Drislane FW. Depth of EEG suppression and outcome in barbiturate anesthetic treatment for refractory status epilepticus. Epilepsia. 1999;40:759–62.

Shorvon S, Baulac M, Cross H, Trinka E, Walker M. The drug treatment of status epilepticus in Europe: consensus document from a workshop at the first London Colloquium on Status Epilepticus. Epilepsia. 2008;49:1277–85.